» Articles » PMID: 33151416

Bone Fracture Healing: Perspectives According to Molecular Basis

Overview
Specialty Endocrinology
Date 2020 Nov 5
PMID 33151416
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Fractures have a great impact on health all around the world and with fracture healing optimization; this problem could be resolved partially. To make a practical contribution to this issue, the knowledge of bone tissue, cellularity, and metabolism is essential, especially cytoskeletal architecture and its transformations according to external pressures. Special physical and chemical characteristics of the extracellular matrix (ECM) allow the transmission of mechanical stimuli from outside the cell to the plasmatic membrane. The osteocyte cytoskeleton is conformed by a complex network of actin and microtubules combined with crosslinker proteins like vinculin and fimbrin, connecting and transmitting outside stimuli through EMC to cytoplasm. Herein, critical signaling pathways like Cx43-depending ones, MAPK/ERK, Wnt, YAP/TAZ, Rho-ROCK, and others are activated due to mechanical stimuli, resulting in osteocyte cytoskeletal changes and ECM remodeling, altering the tissue and, therefore, the bone. In recent years, the osteocyte has gained more interest and value in relation to bone homeostasis as a great coordinator of other cell populations, thanks to its unique functions. By integrating the latest advances in relation to intracellular signaling pathways, mechanotransmission system of the osteocyte and bone tissue engineering, there are promising experimental strategies, while some are ready for clinical trials. This work aims to show clearly and precisely the integration between cytoskeleton and main molecular pathways in relation to mechanotransmission mechanism in osteocytes, and the use of this theoretical knowledge in therapeutic tools for bone fracture healing.

Citing Articles

mpECs with high Piezo2 expression promote fracture healing by driving angiogenesis through the Notch signaling pathway.

He L, Gong F, Wang J, Huang Y, Wang H BMC Musculoskelet Disord. 2025; 26(1):238.

PMID: 40069682 PMC: 11895173. DOI: 10.1186/s12891-025-08476-4.


Revealing the core active pharmaceutical ingredients and targets of Jie-gu capsules for fracture treatment through network pharmacology and mendelian randomization.

Wang Y, Ding S, Gao F, Jia Y, Wang X Medicine (Baltimore). 2024; 103(49):e40798.

PMID: 39654220 PMC: 11630937. DOI: 10.1097/MD.0000000000040798.


Biocompatibility and bone regeneration with elastin-like recombinamer-based catalyst-free click gels.

Camal Ruggieri I, Aimone M, Juanes-Gusano D, Ibanez-Fonseca A, Santiago O, Stur M Sci Rep. 2024; 14(1):20223.

PMID: 39215050 PMC: 11364658. DOI: 10.1038/s41598-024-69658-z.


Regulator of G protein signalling 18 promotes osteocyte proliferation by activating the extracellular signal‑regulated kinase signalling pathway.

Meng Y, Qiu S, Wang Q, Zuo J Int J Mol Med. 2024; 53(3).

PMID: 38214344 PMC: 10836495. DOI: 10.3892/ijmm.2024.5346.


Long non-coding RNA KCNQ10T1/miR-19a-3p/SMAD5 axis promotes osteogenic differentiation of mouse bone mesenchymal stem cells.

Lin H, Nie L, Lu G, Wu H, Xu T J Orthop Surg Res. 2023; 18(1):929.

PMID: 38057885 PMC: 10698940. DOI: 10.1186/s13018-023-04425-w.


References
1.
Poorman G, Segreto F, Beaubrun B, Jalai C, Horn S, Bortz C . Traumatic Fracture of the Pediatric Cervical Spine: Etiology, Epidemiology, Concurrent Injuries, and an Analysis of Perioperative Outcomes Using the Kids' Inpatient Database. Int J Spine Surg. 2019; 13(1):68-78. PMC: 6383458. DOI: 10.14444/6009. View

2.
Oden A, McCloskey E, Kanis J, Harvey N, Johansson H . Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int. 2015; 26(9):2243-8. DOI: 10.1007/s00198-015-3154-6. View

3.
Ensrud K . Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci. 2013; 68(10):1236-42. DOI: 10.1093/gerona/glt092. View

4.
Dey M, Bukhari M . Predictors of fracture risk in patients with systemic lupus erythematosus. Lupus. 2018; 27(9):1547-1551. DOI: 10.1177/0961203318768886. View

5.
Compston J . Type 2 diabetes mellitus and bone. J Intern Med. 2017; 283(2):140-153. DOI: 10.1111/joim.12725. View